Volume 28, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



A biological test system has been developed to assess the prophylactic activity of compounds against sporozoite-induced malaria in mice. The procedure was designed to serve as the foundation of an effor to develop tissue schizonticidal drugs in a manner parallel to that of a previous system employed in the U.S. Army Antimalarial Drug Development Program to screen compounds for blood schizonticidal activity. In tests with 35 known antimalarial compounds, the new screen was found to be in agreement 93% and 80%, respectively, when assessed compound activity was compared with results obtained in a definitive mouse causal prophylactic test and a rhesus monkey radical curative system.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error